Sulforaphane Skincare Composition With On-Demand Precursor Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing skincare products lack effective utilization of sulforaphane due to its rapid instability and sensitivity to environmental triggers, limiting its use as an antioxidant and anti-inflammatory agent.
Innovation Solution
A skincare composition comprising stabilized glucoraphanin and myrosinase in a powdered form, which reacts with a liquid activator to create sulforaphane upon application, ensuring minimal degradation and optimal potency on the skin surface.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sulforaphane is directly used in skincare products, then antioxidant and anti-inflammatory benefits are achieved, but the compound rapidly degrades and loses potency due to environmental sensitivity
Solution Approach 1:
The patent divides the unstable sulforaphane molecule into two stable precursor components: glucoraphanin and myrosinase. These segments are separately stabilized and stored, then recombined on-demand to generate active sulforaphane, thereby resolving the contradiction between stability and potency duration.
Solution Approach 2:
The patent performs preliminary stabilization of the precursor components (glucoraphanin and myrosinase) during product formulation, protecting them from degradation. The active sulforaphane is then generated in-situ at the point of use through controlled enzymatic conversion, ensuring both stability during storage and potency when applied.
2Stability of the object's composition
If stabilized precursor components are used instead of direct sulforaphane, then stability and shelf-life are improved, but the product complexity increases due to multiple components and activation requirements
Solution Approach 1:
The patent employs self-service by incorporating myrosinase enzyme that automatically converts glucoraphanin to sulforaphane upon contact with moisture from the skin or environment. This self-activating mechanism eliminates the need for complex external activation systems, reducing product complexity while maintaining stability.
Solution Approach 2:
The patent uses myrosinase as an intermediary substance that mediates the conversion between stable glucoraphanin and active sulforaphane. This intermediary enables controlled generation of the active compound without requiring complex formulation techniques, thereby improving stability while managing product complexity.
3Object-affected harmful factors
If sulforaphane is applied topically to achieve anti-aging benefits, then skin protection is enhanced, but the compound degrades before penetrating and acting on the skin surface
Solution Approach 1:
The patent performs preliminary stabilization of precursor components in the formulation, ensuring they remain intact during storage and application. The active sulforaphane is then generated in-situ at the moment of skin contact, eliminating the time loss associated with transporting and stabilizing pre-formed sulforaphane to the skin surface.
Solution Approach 2:
The patent extracts the unstable sulforaphane from the final formulation and replaces it with stable precursors that generate sulforaphane in-situ at the application site. This extraction of the problematic compound while retaining its function through precursor conversion resolves the time loss issue by generating the active ingredient exactly when and where it is needed.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively delivers sulforaphane to the skin, providing potent antioxidant and anti-inflammatory benefits, enhancing skin health and stability through controlled activation.
Implementation Method 1
the predetermined amount of the one or more cruciferous vegetables including stabilized glucoraphanin and active myrosinase in a stable state; wherein exposing the powdered substance to a liquid activator causes a chemical reaction between the stabilized glucoraphanin and the active myrosinase to create sulforaphane
Implementation Method 2
causes a chemical reaction between the stabilized glucoraphanin and the active myrosinase to create sulforaphane
Data Source
AI summary
A skincare composition includes a substance having a predetermined amount of one or more cruciferous vegetables, the predetermined amount of the one or more cruciferous vegetables including stabilized glucoraphanin and active myrosinase in a stable state; exposing the substance to a liquid activator causes a chemical reaction between the stabilized glucoraphanin and the active myrosinase to create sulforaphane in an active product; and applying the activated product to a skin surface allows the sulforaphane to act upon the skin surface.